Teladoc Health (NYSE:TDOC) Given Overweight Rating at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Teladoc Health (NYSE:TDOC) in a research note released on Tuesday, Benzinga reports. They currently have a $10.00 price target on the health services provider’s stock.

TDOC has been the topic of a number of other reports. JPMorgan Chase & Co. reduced their price target on shares of Teladoc Health from $19.00 to $16.00 and set a neutral rating on the stock in a research report on Tuesday, May 21st. Truist Financial reduced their price target on Teladoc Health from $15.00 to $10.00 and set a hold rating for the company in a report on Friday, August 2nd. Barclays reduced their price target on Teladoc Health from $20.00 to $10.00 and set an overweight rating for the company in a report on Thursday, August 1st. Stifel Nicolaus reduced their price objective on Teladoc Health from $16.00 to $9.00 and set a hold rating for the company in a report on Thursday, August 1st. Finally, Needham & Company LLC restated a hold rating on shares of Teladoc Health in a research note on Thursday, August 1st. Fourteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of Hold and an average price target of $12.85.

Teladoc Health Stock Up 4.4 %

NYSE:TDOC opened at $7.42 on Tuesday. The company has a market cap of $1.26 billion, a PE ratio of -5.04 and a beta of 0.93. Teladoc Health has a one year low of $6.77 and a one year high of $23.24. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. The firm’s 50 day simple moving average is $8.84 and its 200 day simple moving average is $12.43.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.08. The firm had revenue of $642.44 million during the quarter, compared to analyst estimates of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. On average, research analysts anticipate that Teladoc Health will post -0.7 earnings per share for the current year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the firm’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the transaction, the insider now owns 33,667 shares of the company’s stock, valued at $274,049.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Laizer Kornwasser sold 10,879 shares of the firm’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $88,555.06. Following the sale, the chief executive officer now owns 99,929 shares in the company, valued at $813,422.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the completion of the transaction, the insider now owns 33,667 shares in the company, valued at approximately $274,049.38. The disclosure for this sale can be found here. Insiders sold 42,880 shares of company stock valued at $355,689 in the last ninety days. Corporate insiders own 0.95% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. ICA Group Wealth Management LLC purchased a new stake in shares of Teladoc Health during the fourth quarter worth about $28,000. Signaturefd LLC boosted its stake in Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after acquiring an additional 1,715 shares during the period. International Assets Investment Management LLC acquired a new position in shares of Teladoc Health during the second quarter worth approximately $29,000. Hexagon Capital Partners LLC boosted its position in shares of Teladoc Health by 204.4% during the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after buying an additional 1,065 shares during the period. Finally, GAMMA Investing LLC acquired a new position in shares of Teladoc Health during the fourth quarter worth approximately $41,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.